1. Home
  2. DK vs ABCL Comparison

DK vs ABCL Comparison

Compare DK & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

N/A

Current Price

$76.10

Market Cap

3.4B

Sector

Energy

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$10.89

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DK
ABCL
Founded
2001
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.5B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
DK
ABCL
Price
$76.10
$10.89
Analyst Decision
Hold
Strong Buy
Analyst Count
17
5
Target Price
$39.94
$8.40
AVG Volume (30 Days)
1.5M
6.6M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
2.19%
N/A
EPS Growth
95.67
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
$6.85
N/A
Revenue Next Year
N/A
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
160.56
52 Week Low
$25.85
$2.75
52 Week High
$77.40
$12.58

Technical Indicators

Market Signals
Indicator
DK
ABCL
Relative Strength Index (RSI) 61.95 50.98
Support Level $58.20 $10.44
Resistance Level $77.40 $12.58
Average True Range (ATR) 4.26 0.65
MACD 0.17 -0.29
Stochastic Oscillator 77.92 0.70

Price Performance

Historical Comparison
DK
ABCL

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has three segments: Refining segment and Logistics segment and retail segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: